- Investing Ideas
- /
- U.S. Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Strong Past Earnings Growth, P/E Ratio Below 20
Results
148
21 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
148 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BRK.A | US$702,613.50 | 1.2% | 19.2% | US$1.0t | US$748,611.00 | PE9.5x | E-22.1% | n/a | Diversified Financials | ||
QCOM | US$172.93 | 0.5% | 22.0% | US$190.0b | US$202.61 | PE18.9x | E6.6% | 2.0% | Semiconductors | ||
JD | US$40.72 | 0% | 87.0% | US$61.3b | US$50.02 | PE12.3x | E7.8% | 1.8% | Retail | ||
RJF New | US$168.48 | -2.4% | 49.9% | US$34.9b | US$173.93 | PE16x | E5.8% | 1.2% | Diversified Financials | ||
HIG | US$111.55 | 0.05% | 23.5% | US$32.9b | US$129.00 | PE10.4x | E6.5% | 1.9% | Insurance | ||
CNC | US$64.03 | -0.9% | -15.1% | US$32.6b | US$79.45 | PE10.5x | E3.3% | n/a | Healthcare | ||
DOV New | US$203.68 | 2.5% | 28.3% | US$28.2b | US$222.08 | PE20x | E-1.4% | 1.0% | Capital Goods | ||
HPE | US$21.19 | -13.0% | 37.5% | US$27.9b | US$24.48 | PE10.9x | E0.4% | 2.5% | Tech | ||
TROW | US$116.92 | 2.4% | 6.5% | US$26.0b | US$113.36 | PE12.7x | E1.9% | 4.2% | Diversified Financials | ||
WRB New | US$58.83 | 2.3% | 9.1% | US$22.5b | US$63.26 | PE12.7x | E3.1% | 2.4% | Insurance | ||
L | US$85.45 | 0.7% | 17.0% | US$18.8b | n/a | PE11.1x | n/a | 0.3% | Insurance | ||
KSPI | US$95.10 | 0.4% | 3.3% | US$18.6b | US$126.60 | PE9.6x | E20.8% | 6.9% | Diversified Financials | ||
MOH | US$310.41 | 2.0% | -12.5% | US$17.9b | US$357.67 | PE15.5x | E13.5% | n/a | Healthcare | ||
CSL New | US$389.46 | -3.3% | 21.3% | US$17.8b | US$471.67 | PE19.7x | E7.1% | 1.0% | Capital Goods | ||
BF.B | US$33.01 | -2.7% | -41.9% | US$15.7b | US$45.47 | PE15.5x | E3.3% | 2.7% | Food, Beverage & Tobacco | ||
UTHR | US$351.17 | -5.3% | 64.6% | US$15.7b | US$402.16 | PE14.1x | E10.1% | n/a | Pharmaceuticals & Biotech | ||
EG | US$347.51 | -4.8% | -8.9% | US$15.1b | US$415.73 | PE5.5x | E11.5% | 2.3% | Insurance | ||
UNM | US$76.25 | 1.7% | 61.1% | US$14.1b | US$82.92 | PE7.9x | E-3.9% | 2.2% | Insurance | ||
CNA | US$49.06 | 0.7% | 13.3% | US$13.4b | US$48.50 | PE10.2x | E15.7% | 7.7% | Insurance | ||
SF | US$115.85 | 1.4% | 55.0% | US$12.0b | US$122.00 | PE17.1x | E10.8% | 1.6% | Diversified Financials | ||
AIZ | US$215.19 | 2.0% | 29.0% | US$11.2b | US$228.00 | PE14.9x | E13.7% | 1.5% | Insurance | ||
SEIC New | US$86.58 | 2.0% | 29.9% | US$10.9b | US$89.00 | PE18.9x | E6.1% | 1.1% | Diversified Financials | ||
NVT New | US$65.09 | -13.0% | 2.6% | US$10.9b | US$81.80 | PE18.6x | E-0.04% | 1.2% | Capital Goods | ||
ORI | US$36.58 | 1.0% | 31.9% | US$9.3b | US$40.50 | PE10.8x | E-1.4% | 2.9% | Insurance |